Table 3 Independent predictors of stage 1, stage 2, stage 3 and stages 4–5 CKD in the overall study population

From: Clinical correlates of renal dysfunction in hypertensive patients without cardiovascular complications: the REDHY study

Variable

Estimate (s.e.)

Odds ratio

95% Confidence Interval

P

   

Lower

Upper

 

Stage 1

 Age

−0.05 (0.014)

0.951

0.926

0.977

<0.001

 Systolic blood pressure

0.016 (0.004)

1.014

1.003

1.025

0.009

 Waist circumference

0.025 (0.012)

1.026

1.004

1.050

0.026

 Pharmacological treatment for hypertension

0.78 (0.434)

2.18

0.932

5.102

0.072

Stage 2

 Systolic blood pressure

0.02 (0.006)

1.020

1.007

1.033

0.002

 Waist circumference

0.032 (0.013)

1.029

1.009

1.052

0.004

 Pharmacological treatment for hypertension

0.644 (0.281)

1.888

1.061

3.390

0.037

Stage 3

 Age

0.086 (0.017)

1.090

1.053

1.128

<0.001

 Serum uric acid

0.538 (0.119)

1.713

1.358

2.162

<0.001

 Waist circumference

−0.055 (0.021)

0.947

0.908

0.987

0.01

 Systolic blood pressure

0.02 (0.009)

1.021

1.004

1.038

0.018

Stages 4–5

 Serum uric acid

1.026 (0.207)

2.79

1.859

4.188

<0.001

 Waist circumference

−0.115 (0.043)

0.891

0.820

0.969

0.007